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Abstract
Background: Post-radiation sarcoma (PRS) is an uncommon disease manifesting as sarcoma in a
previously irradiated field, usually with a latent period of 5 years or more. Literature is limited to
small series. Optimal management of this disease is unclear. Positive margins are common following
attempted curative surgery and outcomes are poor. Radiotherapy is hardly used and its effect on
PRS is not known. We described a case of PRS treated with preoperative radiotherapy followed by
margin-negative wide excision.
Case presentation: The 59-year-old patient presented with a mass in the left supraclavicular
fossa and numbness in the arm, six years following radical irradiation of the head and neck for
nasopharyngeal carcinoma. Open biopsy showed pleomorphic spindle cell sarcoma. She was
treated with pre-operative hyperfractionated radiotherapy followed by margin-negative wide
excision and nerve grafting. Cumulative radiation dose to the supraclavicular fossa was 98 Gy.
Histological examination of the post-irradiation tumor specimens showed evidence of significant
tumor response to re-irradiation. The patient remained free of disease five years after surgery with
excellent functional outcome.
Conclusion: Role of radiotherapy in PRS is uncertain. We described a case that was successfully
managed with preoperative radiotherapy and margin-negative wide excision in terms of tumor
control and functional outcomes. The impact of radiotherapy was demonstrated in the post-
irradiation resected specimen. Further investigation using re-irradiation and surgery in PRS is
warranted.
Background
Post-radiation sarcoma (PRS) is an uncommon disease. It
occurs in approximately 0.2% of patients treated with
radiotherapy that survive at least five years [1], with a wide
latent period between initial irradiation and development
of sarcoma ranging from 4–55 years [2]. Outcomes are
generally poor: 5-year overall survival figures of 11 – 29%
have been quoted [3,4] for all groups and for those who
have a curative resection the 5 year survival is approxi-
mately 40% [5]. Survival figures are worse for proximally
situated tumors [6]. Poor survival is multifactorial: mar-
gin-negative surgery is often difficult as tumors are more
likely to be large [7], and there is a high-risk of distant
metastasis.
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Standard treatment for PRS is radical resection. There is a
paucity of chemotherapeutic agents that have shown effi-
cacy in the management of PRS [6]. The role of adjuvant
therapy has not been defined. Although radiation therapy
has an established role in the management of soft tissue
sarcoma [8,9], it is seldom used in PRS. The reason for this
is usually multifactorial. The normal tissues surrounding
the PRS have usually been irradiated to near-tolerance
radiation doses during the initial radiation therapy. The
efficacy of radiation in PRS is uncertain. There is also the
potential risk of inducing another malignancy.
In this report, we described the case of a patient with PRS
involving the supraclavicular fossa and brachial plexus
following successful treatment of nasopharyngeal carci-
noma with radiotherapy five years earlier. Preoperative
accelerated hyperfractionated radiotherapy was used fol-
lowed by en bloc resection and nerve grafting, leaving the
patient with an excellent functional outcome and free of
disease five years following surgery.
Case presentation
The patient, a 59-year-old Chinese woman, was treated at
our centre in 1994 for a T3N0M0 nasopharyngeal carci-
noma. She was treated with external beam radiotherapy to
60 Gy in 30 fractions over 6 weeks in accordance to ICRU-
50. Two lateral parallel opposed fields were used to treat
the nasopharynx and upper neck. The lower neck was irra-
diated with a direct anterior field with a central cord
shield and a lower border just below clavicular heads. The
junction of the upper and lower field was at the level of
hyoid bone. It was followed by a 10 Gy Iridium-192
brachytherapy boost to the nasopharynx. Treatment was
completed in May 1994. She remained well with no fur-
ther recurrence of the nasopharyngeal carcinoma but
developed xerostomia and mild fibrosis of the lower neck.
She re-presented in December 1999 with a mass in the left
supraclavicular fossa and numbness in the arm, but no
motor weakness. The mass was located within the area
previously irradiated to 60 Gy. Her disease was staged
with our standard protocol at the time with MRI of the
neck and shoulder, CT of the chest and functional imag-
ing using thallium-201 scintigraphy [10]. MRI showed a 3
cm × 5 cm mass involving the brachial plexus (Figure 1).
Open biopsy confirmed pleomorphic spindle cell sar-
coma.
The management of her case was discussed in our multi-
disciplinary meeting. The agreed treatment plan was pre-
operative radiotherapy followed by en bloc resection. She
received an accelerated hyperfractionated course of radio-
therapy 48 Gy in 40 fractions (ICRU-50), treating twice a
day over four weeks. The radiation field incorporated the
brachial plexus and used 6 MV photons in an anterior-
weighted, opposed oblique arrangement avoiding the spi-
nal cord. Radiotherapy was completed in February 2000.
Restaging investigations showed that the lesion had
become more cystic on MRI, but its size had not changed.
The degree of thallium-201 scintigraphy uptake had not
changed significantly either. The patient proceeded on to
surgery four weeks later.
Surgery in March 2000 consisted of en bloc resection of the
tumor along with the left sternomastoid and superior and
middle trunks of the brachial plexus. Clavicular osteot-
omy was necessary to allow dissection of the tumor from
the subclavian vessels. Sural nerve grafts were used to
restore continuity of nerve supply from C5 and C6 to the
suprascapular, musculocutaneous and axillary nerves. A
latissimus dorsi myocutaneous flap was raised to close the
defect in the neck. The middle third of the clavicle that
had been reflected downwards was replaced and secured
with a plate and screws.
Histological examination of the surgical specimen
showed evidence of radiotherapy, with large areas of
necrosis and hemorrhage seen both macroscopically and
microscopically. Comparison was made between the
operative specimen and the pre-irradiation biopsy; necro-
sis was not seen in the pre-irradiation specimen (Figures 2
and 3). Surgical excision appeared complete.
Immediate postoperative recovery was uncomplicated.
The patient retained good function in her hand but was
MRI showing soft tissue mass involving the upper branches of  the brachial plexus Figure 1
MRI showing soft tissue mass involving the upper branches of 
the brachial plexus.World Journal of Surgical Oncology 2006, 4:69 http://www.wjso.com/content/4/1/69
Page 3 of 4
(page number not for citation purposes)
left with a flail shoulder and no power in elbow flexion.
She thus underwent cable grafting of the musculocutane-
ous nerve in October 2000, with gradual return of elbow
function following this procedure.
The patient presented again in December 2001 with pain
in the shoulder. X-ray confirmed that there had been non-
union of the osteopaenic clavicle, the plate having
detached from the lateral end of the clavicle. She returned
to theatre and had a bone graft and internal fixation (Fig-
ure 4). Following this procedure, pain settled and she con-
tinues to have good use of her arm, although shoulder
movement remains minimal.
The patient remains well five years after combined therapy
for the PRS, with no evidence of recurrence of either her
nasopharyngeal carcinoma or the PRS. The patient had no
lymphoedema, neurovascular, severe fibrosis or other sig-
nificant late effect as a result of re-irradiation.
Discussion
This case demonstrates that PRS can be effectively man-
aged with preoperative radiotherapy and surgery, provid-
ing excellent long-term control without necessarily
sacrificing function. The intent of radiotherapy was to
sterilize the microscopic disease at the periphery of the
PRS in order to maximize the chance of local control, as
the extent of the surgical resection was limited by the anat-
omy of the supraclavicular fossa.
Complete resection rates in PRS are relatively low; approx-
imately 50% of patients undergoing attempted curative
resection are left with either macroscopic or microscopic
residual disease [5]. Even with clear margins, local recur-
rence rates are approximately 50% in small series [6]. In
this case, preoperative radiotherapy was given to try to
increase the likelihood of margin-negative surgery, espe-
cially given the difficulty in achieving wide surgical mar-
gins in a region such as the supraclavicular fossa, which is
densely packed with major vessels and nerves. If preoper-
ative radiotherapy had been omitted and margins at sur-
gery are close or positive, postoperative radiotherapy
would have been necessary to achieve long-term control.
This would have necessitated a higher total dose and
larger volume than in the preoperative setting for the
same outcome [8], and would result in greater incidence
Alignment of the clavicle following bone grafting and internal  fixation Figure 4
Alignment of the clavicle following bone grafting and internal 
fixation. The open biopsy showing pleomorphic spindle cell sarcoma Figure 2
The open biopsy showing pleomorphic spindle cell sarcoma.
The surgical specimen showing areas of necrosis and hemor- rhage following radiotherapy Figure 3
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of long-term toxicity such as fibrosis, oedema and joint
stiffness than pre-operative radiation [11].
The brachial plexus was one of the dose-limiting struc-
tures at risk of late effects following re-irradiation. The
dose of 48 Gy was delivered in fraction sizes of 1.2 Gy:
biologically equivalent to 38 Gy in 2 Gy fractions (using
an α:β ratio of 2) and thus a total dose to the brachial
plexus of 98 Gy – considerably higher than the TD5/5 tol-
erance dose of the brachial plexus, which is approximately
62 Gy [12]. However the planned and necessary curative
surgery involved sacrifice of two of the three trunks of the
brachial plexus and immediate sural nerve grafting. The
development of radiation neuropathy was therefore con-
sidered an acceptable risk as many of the structures at risk
were to be resected along with the tumor.
Histological examination of the surgical specimen
showed that there were large areas of necrosis and hemor-
rhage in the specimen, which were not evident on review
of the pre-irradiation open biopsy. Although the response
of PRS to radiation has not been widely studied, it is tra-
ditionally thought to be relatively insensitive to radiation.
This histological finding suggests that the radiotherapy
had a significant tumoricidal effect and may have
enhanced the surgeon's ability to achieve clear surgical
margins despite the difficult location of the tumor. It may
also have sterilized subclinical areas of disease adjacent to
the tumor, contributing to her long-term disease control.
There was non-union of the osteopaenic clavicle follow-
ing her initial surgery, which culminated in separation of
the plate from the lateral end of the clavicle and bearing
of the arm's weight by the rotator cuff muscles, which then
resulted in pain and spasm. Pathologic fracture and frac-
ture non-union is well described in the post-radiotherapy
setting [13] and is thought to be related to injury to oste-
oprogenitor cells, damage to Haversian canals and reduc-
tion in new vessel formation at the fracture site [14].
Successful repair of the fracture was achieved by bone
grafting and internal fixation.
Conclusion
Role of radiotherapy in PRS is uncertain. We described a
case that was successfully managed with preoperative
radiotherapy and margin-negative wide excision in terms
of tumor control and functional outcomes. The impact of
radiotherapy was demonstrated in the post-irradiation
resected specimen. Further investigation using re-irradia-
tion and surgery in PRS is warranted.
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